Mindfulness meditation programs for younger breast cancer survivors
Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings
Two short digital mindfulness programs will be offered to younger breast cancer survivors to help reduce depression, fatigue, insomnia, and cancer-related stress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11329239 on NIH RePORTER |
What this research studies
If you join, you will be randomly assigned to one of two brief mindfulness programs delivered through a digital app or online platform and asked to use it over a set period. You will complete questionnaires about mood, sleep, fatigue, hot flashes, and quality of life at several time points. The trial runs in both clinic and community cancer settings, so care teams at participating sites will help with enrollment and follow-up. The goal is to find which digital format best supports younger women after breast cancer treatment.
Who could benefit from this research
Good fit: Women who were diagnosed with breast cancer at age 50 or younger and are in the survivorship period, especially those experiencing depression, fatigue, insomnia, or cancer-related stress, are the ideal candidates.
Not a fit: Older survivors (diagnosed after age 50), people currently unable to use digital tools, or those with rapidly progressing active disease may not be suited to or benefit from this trial.
Why it matters
Potential benefit: If successful, the programs could lower depression and improve sleep, fatigue, and overall quality of life for younger breast cancer survivors.
How similar studies have performed: In-person mindfulness programs have helped cancer survivors with mood and quality of life, and early digital mindfulness trials show promise but have mixed results, so this larger phase III trial aims to provide clearer evidence.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Bower, Julienne E — University of California Los Angeles
- Study coordinator: Bower, Julienne E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.